Skip to content
sellWeak cluster of 2

Nicholas Hollmeyer Lynton sold $40k of CDLX

Chief Legal & Privacy Officer at Cardlytics, Inc.. 40,296 shares at an average of $0.99, traded Apr 1, 2026, filed Apr 2, 2026.

Warning score
19
Value
$40k
40,296 shares
Holdings after
167,856
-19% from before
From 52-week low
+49%
low $6.69, close $10.00
From 52-week high
-68%
high $31.20, as of Apr 1, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $40k at market
    +6
  • Share of holdings sold
    Sold 19% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -19.0%, 3m -60.4%, 6m -76.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CDLXOct 9, 2026 · close 2.06
Since filing Apr 2, 2026: -81.8%SPY +19.3% · excess -101.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-26-023348, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 1, 2026MOption exercise
Common Stock
+582--123,444Apr 2, 2026
Apr 1, 2026MOption exercise
Common Stock
+1,578--125,022Apr 2, 2026
Apr 1, 2026MOption exercise
Common Stock
+10,630--135,652Apr 2, 2026
Apr 1, 2026MOption exercise
Common Stock
+12,500--148,152Apr 2, 2026
Apr 1, 2026MOption exercise
Common Stock
+60,000--208,152Apr 2, 2026
Apr 1, 2026SOpen-market sale
Common Stock
-40,296$0.99$40k167,856Apr 2, 2026
Apr 1, 2026MOption exercise
Restricted Stock Unitsderivative
-582$0.00$00Apr 2, 2026
Apr 1, 2026MOption exercise
Restricted Stock Unitsderivative
-1,578$0.00$01,578Apr 2, 2026
Apr 1, 2026MOption exercise
Restricted Stock Unitsderivative
-10,630$0.00$00Apr 2, 2026
Apr 1, 2026MOption exercise
Restricted Stock Unitsderivative
-12,500$0.00$012,500Apr 2, 2026
Apr 1, 2026MOption exercise
Restricted Stock Unitsderivative
-60,000$0.00$060,000Apr 2, 2026

Related signals

Other insiders at Cardlytics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$47k
17,733 shares
-11%
17Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$54k
13,461 shares
-10%
13Weak
CDLXsell 2
Cardlytics, Inc.
Nicholas Hollmeyer Lynton
Chief Legal & Privacy Officer
$9,454
2,151 shares
-10%
31Weak
CDLXsell 2
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$71k
16,138 shares
-12%
61Notable
CDLXbuy
Cardlytics, Inc.
David Thomas Evans
Chief Financial Officer
$129k
200,000 shares
+170%
42Moderate
CDLXsell 2
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$83k
69,833 shares
-7%
28Weak
CDLXsell 2
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$118k
116,774 shares
-10%
24Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$89k
97,208 shares
-13%
22Weak
CDLXsell 3
Cardlytics, Inc.
Alexis DeSieno
Chief Financial Officer
$10k
8,607 shares
-4%
25Weak
CDLXsell 3
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$6,794
5,807 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nicholas Hollmeyer Lynton sold $40k of CDLX | InsiderTell